Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
An Open-Label, Phase II, Randomized, Controlled Study of Danvatirsen Plus Pembrolizumab Compared to Pembrolizumab Alone in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)
Sponsored by Flamingo Therapeutics (Belgium)
Active
$275K Funding
1 People
External
Related Topics
immunotherapy,
clinical trial,
head and neck cancer,
combination therapy,
genetic therapy
People
Linda Garland
Co-Investigator (COI)
Medicine
﹒Professor
